These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7924827)

  • 1. Nicotinamide treatment in the prevention of insulin-dependent diabetes mellitus.
    Mandrup-Poulsen T; Reimers JI; Andersen HU; Pociot F; Karlsen AE; Bjerre U; Nerup J
    Diabetes Metab Rev; 1993 Dec; 9(4):295-309. PubMed ID: 7924827
    [No Abstract]   [Full Text] [Related]  

  • 2. Type 1 (insulin-dependent) diabetes mellitus and nitric oxide.
    Kolb H; Kolb-Bachofen V
    Diabetologia; 1992 Aug; 35(8):796-7. PubMed ID: 1387373
    [No Abstract]   [Full Text] [Related]  

  • 3. [Nicotinamide and prevention of insulin-dependent diabetes mellitus. Rationale, effects, toxicology and clinical experiences. ENDIT Group].
    Reimers JI; Andersen HU; Pociot F
    Ugeskr Laeger; 1994 Jan; 156(4):461-5. PubMed ID: 8140661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot trial to prevent type I diabetes: progression to overt IDDM despite oral nicotinamide.
    Herskowitz RD; Jackson RA; Soeldner JS; Eisenbarth GS
    J Autoimmun; 1989 Oct; 2(5):733-7. PubMed ID: 2529865
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulation of antigen expression in relation to intervention strategies in type 1 diabetes.
    Di Mario U; Dotta F
    Diabetes Metab Rev; 1993 Dec; 9(4):245-9. PubMed ID: 7924821
    [No Abstract]   [Full Text] [Related]  

  • 6. New developments in non-specific and semi-specific immunosuppression in type I diabetes.
    Leslie RD; Carotenuto P; Pozzilli P
    Diabetes Metab Rev; 1993 Dec; 9(4):257-67. PubMed ID: 7924823
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin, beta-cell rest, and high risk of type I diabetes mellitus.
    Rodríguez Villar C; Vidal J; González-Clemente JM; Gomis R
    Lancet; 1993 May; 341(8855):1291. PubMed ID: 8098441
    [No Abstract]   [Full Text] [Related]  

  • 8. The case for elimination of cow's milk in early infancy in the prevention of type 1 diabetes: the Finnish experience.
    Akerblom HK; Savilahti E; Saukkonen TT; Paganus A; Virtanen SM; Teramo K; Knip M; Ilonen J; Reijonen H; Karjalainen J
    Diabetes Metab Rev; 1993 Dec; 9(4):269-78. PubMed ID: 7924824
    [No Abstract]   [Full Text] [Related]  

  • 9. High dose nicotinamide fails to prevent diabetes in BB rats.
    Hermitte L; Vialettes B; Atlef N; Payan MJ; Doll N; Scheimann A; Vague P
    Autoimmunity; 1989; 5(1-2):79-86. PubMed ID: 2535259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinamide: potential for the prevention of type 1 diabetes?
    Gale EA
    Horm Metab Res; 1996 Jul; 28(7):361-4. PubMed ID: 8858387
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pre-diabetes type 1. Evaluation of current clinical trials].
    Thivolet C
    Journ Annu Diabetol Hotel Dieu; 1997; ():201-5. PubMed ID: 9296975
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental models of juvenile onset (insulin-dependent) diabetes mellitus.
    Craighead JE
    Monogr Pathol; 1980; 21():166-76. PubMed ID: 6261120
    [No Abstract]   [Full Text] [Related]  

  • 13. [The autoimmune mechanisms of the development of insulin-dependent diabetes mellitus].
    Shishko PI
    Ter Arkh; 1991; 63(6):l46-51. PubMed ID: 1948721
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of standard nicotinamide in the prevention of type 1 diabetes in first degree relatives of persons with type 1 diabetes.
    Cabrera-Rode E; Molina G; Arranz C; Vera M; González P; Suárez R; Prieto M; Padrón S; León R; Tillan J; García I; Tiberti C; Rodríguez OM; Gutiérrez A; Fernández T; Govea A; Hernández J; Chiong D; Domínguez E; Di Mario U; Díaz-Díaz O; Díaz-Horta O
    Autoimmunity; 2006 Jun; 39(4):333-40. PubMed ID: 16891222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotinamide inhibits enhanced in vitro production of interleukin-12 and tumour necrosis factor-alpha in peripheral whole blood of people at high risk of developing type 1 diabetes and people with newly diagnosed type 1 diabetes.
    Kretowski A; Myśliwiec J; Szelachowska M; Kinalski M; Kinalska I
    Diabetes Res Clin Pract; 2000 Feb; 47(2):81-6. PubMed ID: 10670906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The design of trials for prevention of IDDM.
    Eisenbarth GS; Verge CF; Allen H; Rewers MJ
    Diabetes; 1993 Jul; 42(7):941-7. PubMed ID: 7646584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for macrophages in the pathogenesis of type 1 diabetes.
    Kolb-Bachofen V; Kolb H
    Autoimmunity; 1989; 3(2):145-54. PubMed ID: 2491626
    [No Abstract]   [Full Text] [Related]  

  • 18. [Etiology of insulin-dependent diabetes mellitus].
    Kuzuya T
    Nihon Rinsho; 1990 Dec; 48 Suppl():187-95. PubMed ID: 2086888
    [No Abstract]   [Full Text] [Related]  

  • 19. Prediabetes: prediction and prevention trials.
    Vendrame F; Gottlieb PA
    Endocrinol Metab Clin North Am; 2004 Mar; 33(1):75-92, ix. PubMed ID: 15053896
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunoprevention of Type I diabetes mellitus].
    Spinas GA
    Ther Umsch; 1996 Dec; 53(12):882-8. PubMed ID: 9036566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.